Avoid even normal consumption of grapefruit juice if potential interaction with oral cardiovascular drugs


    loading  Checking for direct PDF access through Ovid

Abstract

Grapefruit juice, which inhibits gastrointestinal cytochrome P450 3A4 enzymes and the drug transporter P-glycoprotein, interacts with several oral cardiovascular drugs. Consumption of as little as a glassful of the juice may result in a clinically relevant pharmacokinetic interaction. Therefore, it is prudent to avoid consumption of grapefruit juice during pharmacotherapy with drugs that are expected to interact with the juice.

    loading  Loading Related Articles